https://www.selleckchem.com/pr....oducts/bay-1217389.h
Younger age was found to impact use of antibacterial therapy in both the overall analysis as well as the SARS-CoV-2 negative subgroup (P = 0.03 and P = 0.01). High procalcitonin values were found to be associated with increased antibacterial therapy use in both the overall and stratified analyses. Antibacterial therapy prescription differs by COVID-19 disease status, and procalcitonin results are most highly associated with antibacterial use across strata. Antibacterial therapy prescription differs by COVID-19 disease status, and pr
Like
Comment
Share
